All stock lists
Unlock the score
Iridex Corp (NASDAQ:IRIX)
US · Delayed Price · Currency is USD
Healthcare · Medical - Devices
0.75+0.01 (+1.11%)
Market cap
$13.2M
Insider Score
Health Score
Analyst consensus
Listed since
Feb 16, 1996
Website
Insider Score
/ 100
IRIX Insider Score
IRIDEX CORP has a live Insider Score.
Scored on 5 qualifying trades from 1 insider in the last 90 days.
Financial Health Score
Sound
From IRIX’s reported statements · Q3 2026 (trailing 12 months)
Profitability7 / 20
Loses money on what it sells.
- Revenue
- $51.6M
- Net income
- -$3.5M
- Net margin
- -6.9%
Leverage9 / 20
A manageable debt load.
- Total debt
- $4.0M
- Cash
- $4.7M
- Debt / equity
- 1.10
Liquidity18 / 20
Comfortably covers what is due within a year.
- Current assets
- $24.0M
- Current liabilities
- $13.2M
- Current ratio
- 1.82
Cash generation9 / 20
Roughly cash-neutral.
- Operating cash flow
- -$1.7M
- Free cash flow
- -$1.8M
- FCF margin
- -3.4%
Dilution & runway17 / 20
Not funding itself by issuing shares.
- Shares outstanding
- 17.4M
- Share growth (1y)
- 3.5%
- Cash runway
- 32 months
Five pillars — profitability, leverage, liquidity, cash generation, dilution & runway — each scored 0–20 from the company’s own income statement, balance sheet and cash-flow statement, then scaled to 100. A pillar the statements cannot answer is left out rather than guessed; fewer than three and no score is shown.
IRIX Income Statement
| Fiscal Period | Q3 2026 | Q2 2026 | Q1 2026 | Q3 2025 | Q2 2025 | Q1 2025 |
|---|---|---|---|---|---|---|
| Period Ending | Jul 4, 2026 | Apr 4, 2026 | Jan 3, 2026 | Sep 27, 2025 | Jun 28, 2025 | Mar 29, 2025 |
| Revenue | 12.57 M | 11.80 M | 14.72 M | 12.48 M | 13.57 M | 11.90 M |
| Revenue Growth (YoY) | -7.41 % | -0.82 % | 15.97 % | 7.80 % | 7.44 % | 1.15 % |
| Cost of Revenue | 8.27 M | 7.06 M | 9.09 M | 8.47 M | 8.97 M | 6.84 M |
| Gross Profit | 4.30 M | 4.74 M | 5.63 M | 4.01 M | 4.60 M | 5.05 M |
| SG&A Expense | 4.39 M | 4.16 M | 4.54 M | 4.45 M | 4.75 M | 4.38 M |
| R&D Expense | 936.00 K | 905.00 K | 949.00 K | 972.00 K | 871.00 K | 876.00 K |
| Operating Expenses | 5.33 M | 5.07 M | 5.65 M | 5.42 M | 5.54 M | 5.26 M |
| Operating Income | -1.03 M | -324.00 K | -15.00 K | -1.41 M | -940.00 K | -205.00 K |
| Pretax Income | -1.20 M | -466.00 K | -164.00 K | -1.57 M | -973.00 K | -1.67 M |
| Tax Provision | 70.00 K | 58.00 K | 20.00 K | 4.00 K | 21.00 K | 12.00 K |
| Net Income | -1.27 M | -524.00 K | -184.00 K | -1.57 M | -994.00 K | -1.69 M |
| EPS (Basic) | -0.07 | -0.03 | -0.01 | -0.09 | -0.06 | -0.10 |
| EPS (Diluted) | -0.07 | -0.03 | -0.01 | -0.09 | -0.06 | -0.10 |
| Shares Outstanding | 17.38 M | 17.31 M | 17.19 M | 17.01 M | 16.79 M | 16.73 M |
Quarterly figures; YoY compares the same fiscal quarter a year earlier. Source: public market data.
Disclaimer — Informational only — not investment advice. Insider transaction data is sourced from SEC Form 4 filings; market data from public feeds and may be delayed. The Insider Score is a proprietary score for research purposes and does not predict future performance. Always do your own research.